This ambispective cohort study demonstrated a proof of concept that the designed treatment protocol of cryoablation combined with transarterial PD-1 blockade therapy (CATAP) is safe and can achieve antitumor immune response for liver metastasis of melanoma. The gene discussed is PDCD1; the disease is melanoma.